Obstructive Sleep Apnea and Cardiovascular Disease

Clin Geriatr Med. 2021 Aug;37(3):445-456. doi: 10.1016/j.cger.2021.04.006. Epub 2021 Jun 5.

Abstract

Obstructive sleep apnea (OSA) presents as repetitive interruptions of ventilation >10 seconds during sleep as a result of upper airway obstruction resulting in increased respiratory effort. Intermittent hypoxia causes physiologic changes resulting in increased catecholamine production, increased total peripheral resistance, tachycardia, and increased venous return, leading to increased cardiac output, hypertension, tachyarrhythmias, left ventricular hypertrophy, and heart failure. OSA causes an abnormal dip on 24-hour ambulatory blood pressure monitoring. Definitive diagnosis is made by polysomnography. Continuous positive airway pressure (CPAP) remains the first-line treatment. Effective treatment using CPAP reduces blood pressure and is indispensable for proper management of atrial fibrillation.

Keywords: Atrial fibrillation; Hypertension; Nondipper; Obstructive sleep apnea; Polysomnography; Premature ventricular contractions; Ventricular tachycardia.

Publication types

  • Review

MeSH terms

  • Aged
  • Atrial Fibrillation / etiology
  • Cardiovascular Diseases / etiology*
  • Continuous Positive Airway Pressure / adverse effects*
  • Continuous Positive Airway Pressure / methods
  • Electrocardiography, Ambulatory
  • Humans
  • Hypertension / etiology*
  • Polysomnography
  • Sleep Apnea, Obstructive / complications
  • Sleep Apnea, Obstructive / therapy*
  • Tachycardia, Ventricular / etiology